Oxaliplatin manufacturer is a vital chemotherapy drug primarily used in treating colorectal cancer, as well as pancreatic and gastric cancers. As an alkylating agent, it works by interfering with DNA replication, preventing cancer cells from multiplying. Manufactured under the brand name Eloxatin, oxaliplatin is a key component of modern cancer treatment regimens.
Several manufacturers produce oxaliplatin for global healthcare needs. Among the leading producers is Sanofi, which originally brought Eloxatin to the market. The drug is now also available as a generic version from multiple global manufacturers, ensuring broader accessibility and affordability. These manufacturers uphold high-quality standards to provide patients with safe and effective cancer treatment options. Their commitment plays a crucial role in making life-saving therapies available to patients worldwide.